Biosimilars Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035

The global biosimilars market is poised for significant expansion, with its value expected to grow from USD 24.2 billion in 2024 to approximately USD 130.1 billion by 2035, reflecting a compound annual growth rate (CAGR) of 16.5% during this period. This robust growth is driven primarily by the impending patent expiries of blockbuster biologics and the increasing demand for more affordable biologic alternatives that maintain comparable safety and efficacy profiles.

Market Growth Drivers

The biosimilars market growth is fueled by several key factors:

- The expiry of patents on major biologic drugs, which opens the door for biosimilar development and commercialization.
- The rising prevalence of chronic diseases such as oncological, autoimmune, hematological, and metabolic disorders, which increases the demand for effective biologic therapies.

Read More :- https://www.rootsanalysis.com/....reports/biosimilars-